ArsenalBio

formerly Arsenal Biosciences

Engineering Hope®

San Francisco, United States · Founded 2019 · $955.0M raised

Employees
201–500
Founded
2019
Business Model
B2B
Total Funding
$955.0M
Last Round
$325.0M Series CSep 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

ArsenalBio is a clinical-stage programmable cell therapy company engineering advanced CAR T-cell therapies for solid tumors. Using a synthetic biology toolkit, the company genetically programs patients' T cells to eradicate solid tumors and has an ongoing multi-program collaboration with Bristol Myers Squibb to advance next-generation T-cell therapies.

Summary

ArsenalBio is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $955.0M in total across 4 rounds, most recently a $325.0M Series C round in Sep 2024. Investors include ARCH Venture Partners, Bristol Myers Squibb and Kleiner Perkins.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CSep 2024
$325.0M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ArsenalBio on Indexed.vc
<a href="https://indexed.vc/companies/arsenalbio"><img src="https://indexed.vc/api/badge/company/arsenalbio" alt="ArsenalBio on Indexed.vc" width="260" height="76" /></a>